Cooperative Agreement NU2GGH002131

The National Institute of Mental Health (NIMH) awarded a five-year, $710,187 Project Grant (CFDA 93.242) to Research Triangle Institute (RTI International) to adapt and evaluate the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention for increasing pre-exposure prophylaxis (PrEP) adherence and continuation among adolescent girls and young women in South Africa and Zimbabwe. The key objectives are to: 1) adapt the CARES intervention to incorporate injectable PrEP and...

This $2,127,639 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a multi-level integrated strategy to optimize adherence to HIV pre-exposure prophylaxis (PrEP) among Black men who have sex with men (MSM) and accelerate implementation at scale. The primary goal is to combine two evidence-based interventions - Many Men, Many Voices (3MV) and Client-Centered Care Coordination (C4) - to directly...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $381,487 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Maryland, Baltimore (UMB) to assess the implementation and outcomes of introducing long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women at high risk of HIV acquisition in Zambia. The study, titled "Scaling Comprehensively Access to Long-Acting for...

This $1,800,000 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940) aims to strengthen sexual health infrastructure and service delivery for priority populations in New York City. The project, implemented by the New York City Health and Hospitals Corporation (NYCHHC), will expand access to high-quality sexual health services such as HIV testing, STI testing and treatment,...

This Cooperative Agreement award of $1,800,000 from the National Center for HIV/AIDS (CFDA 93.940 - HIV Prevention Activities Health Department Based) will support the Hamilton County Public Health (HCPH) in Ohio to expand access to HIV prevention, testing, and treatment services. The key objectives are to: Enhance the HCPH clinic infrastructure and service delivery for HIV and STI prevention, testing, and linkage to care, with a focus on reaching underserved populations such as women, sex...

This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $205,235 to the University of North Carolina at Chapel Hill (UNC-CH) to conduct a combined microeconomic strengthening and stigma reduction intervention for young people with HIV in Zambia. The key products/services being delivered through this funding include: An 8-week program with two experimental components: (i) a stigma reduction support group providing...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $582,959 to The Johns Hopkins University to integrate a "Universal Test and Connect" (UTC) strategy into two high-volume emergency departments in Cape Town, South Africa. The goal is to expand access to both preventative (pre- and post-exposure prophylaxis) and therapeutic (antiretroviral therapy initiation) HIV services...

The City and County of San Francisco's Public Health Department has been awarded a five-year Cooperative Agreement under the CDC's HIV Prevention Activities Health Department Based program (CFDA 93.940), totaling $1,800,000. Through this funding, the department will launch "Project EXEL (Expand and Elevate)" Cycle 2 to strengthen the delivery of comprehensive, stigma-free sexual health services and work towards the city's goal of achieving "Getting to Zero" - zero new HIV...

This federal Project Grant award of $547,321 from the National Institute of Mental Health (NIMH), under CFDA 93.242 Mental Health Research Grants program, aims to develop and pilot test an intervention called "Kayungirizi" to promote pre-exposure prophylaxis (PrEP) initiation and persistence among male clients of female sex workers (FSW) in Kampala, Uganda. The key components of the intervention involve: 1) Secondary distribution of HIV self-testing (HIVST) kits by FSW to their male...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $6,749,031 cooperative agreement titled "The USHINDI Project" under the Global AIDS program (CFDA 93.067) to the Association De Sante Familiale (ASF), a local non-profit in the Democratic Republic of the Congo (DRC), with support from PATH, a U.S.-based international NGO. The project aims to enhance access to comprehensive HIV/AIDS services and achieve epidemic control in seven health zones in Haut-Katanga province...